Previous 10 | Next 10 |
SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapp...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips 2021 has been an exciting year for BioNano Genomics (NASDAQ: BNGO ) investors. However, when it comes to stocks, excitement can cut both ways. A spectacular run started last Christmas eve. It saw BNGO stock go from be...
SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations of optical genome mapping (OGM) data spanning three major clinical areas of application from...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano (NASDAQ: BNGO ) stock has more going for it than many people may recognize. Among the most exciting is a financial incentive plan for its Saphyr genome mapping system. Source: Natali_ Mis/ShutterStock....
BNGO remains a speculative trade after Q2 revenue fails to give a solid signal of the medical community's acceptance of Saphyr. The mediocre performance is by no means a thesis for shorting the ticker, given the company's robust balance sheet and commercial opportunity for Saphyr. ...
Bionano Genomics (NASDAQ:BNGO) jumped over 6% on Thursday after the company reported ~226% YoY revenue growth in Q2 2021, a historical high for a second quarter. After three consecutive quarters of decline, the revenue growth has gradually accelerated over the past three quarte...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s no denying that shares of life sciences company Bionano Genomics (NASDAQ: BNGO ) aren’t as cheap as they were in 2020. Yet, due to a recent price pullback, BNGO stock is more attractive than...
Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO) Q2 2021 Earnings Call Aug 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript
Bionano Genomics, Inc. (BNGO) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Amy Conrad – Investor Relations Erik Holmlin – Chief Executive Officer Alka Chaubey – Chief Medical Officer Chris Stewart – Chief Financial Officer Confere...
Bionano Genomics (NASDAQ:BNGO) shares rise nearly 4% post market after reporting second-quarter revenue that beat Wall Street estimates, helped by the momentum in the cytogenetics market. The company's chief executive officer Chris Stewart called the quarterly results "very pos...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a multi-site study evaluating the performance and benefits of optical genome mapping (O...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44 th Annual Growth Conference on August 13, 2024. Conference & ...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2024 and to highlight r...